Summary
This prediction ended on 09.11.18 with a price of €18,400,000. Massive losses of -33.33% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Neovacs | - | - | - | - |
| iShares Core DAX® | -3,52 % | -4,99 % | 1,93 % | 50,82 % |
| iShares Nasdaq 100 | 0,26 % | 1,10 % | 15,43 % | 90,84 % |
| iShares Nikkei 225® | -4,95 % | -3,35 % | 29,01 % | 51,21 % |
| iShares S&P 500 | -0,82 % | -0,04 % | 10,81 % | 62,94 % |
According to melinda what are the pros and cons of Neovacs for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Neovacs diskutieren
(Vom Mitglied beendet)